Literature DB >> 13536530

Clinical trial of acepromazine maleate in chronic schizophrenia.

J F COLLARD, R MAGGS.   

Abstract

Entities:  

Keywords:  PHENOTHIAZINE/related compounds; SCHIZOPHRENIA/therapy

Mesh：

Substances：

Year:  1958        PMID： 13536530      PMCID： PMC2029326          DOI： 10.1136/bmj.1.5085.1452

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Discussion on the toxic effect of drugs used in neurological & psychiatric practice.

Authors:  D STAFFORD-CLARK
Journal:  Proc R Soc Med       Date:  1957-08

2.  The use of reserpine in chronic psychotic patients: a controlled trial.

Authors:  L WING
Journal:  J Ment Sci       Date:  1956-07

3.  Insulin and chlorpromazine in schizophrenia; a comparative study in previously untreated cases.

Authors:  R H BOARDMAN; J LOMAS; M MARKOWE
Journal:  Lancet       Date:  1956-09-08       Impact factor: 79.321

4.  Deteriorated psychotic patients; their treatment and its assessment.

Authors:  A A BAKER; J G THORPE
Journal:  J Ment Sci       Date:  1956-10
  4 in total
  3 in total

1.  Acute acepromazine overdose: clinical effects and toxicokinetic evaluation.

Authors:  D Adam Algren; Amber Ashworth
Journal:  J Med Toxicol       Date:  2015-03

2.  Acepromazine inhibits hERG potassium ion channels expressed in human embryonic kidney 293 cells.

Authors:  Young Shin Joo; Hong Joon Lee; Jin-Sung Choi; Ki-Wug Sung
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

3.  Octopamine signaling in the metazoan pathogen Schistosoma mansoni: localization, small-molecule screening and opportunities for drug development.

Authors:  Nelly El-Sakkary; Steven Chen; Michelle R Arkin; Conor R Caffrey; Paula Ribeiro
Journal:  Dis Model Mech       Date:  2018-07-30       Impact factor: 5.758
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.